Literature DB >> 11551485

Exposure of Escherichia coli to intestinal myoelectrical activity-related electric field induces resistance against subsequent UV(254 nm) (UVC) irradiation.

A Wójcik-Sikora1, D Laubitz, S G Pierzynowski, E Grzesiuk.   

Abstract

Survival of Escherichia coli K-12 AB1157 irradiated with UVC (UV(254 nm)) was enhanced after pre-treatment with a low-tension electric field (EF). The EF used was identical to the electrical field generated by the small intestine (myoelectrical migrating complex--MMC), registered in a healthy calf and transmitted into the memory of an EF generator. The EF emitted by the generator was transmitted via electrodes placed in shaken bacterial cultures. The protective effects of the EF on the E. coli survival after exposure to UV were: (i) observed only for the dnaJ(+)dnaK(+) strain, and not for the DeltadnaJdnaK heat shock mutant; (ii) strictly dependent on the temperature at which the bacteria were grown; (iii) most obvious when the bacteria were incubated at 37 degrees C. Moreover, the MMC-related EF and a higher temperature (40 degrees C) show a similar protective effect against UV-irradiation. The results point to the involvement of the heat shock response in the low-tension EF-induced protection of bacterial cells against UVC-irradiation. Additionally, treatment with the MMC-related EF affects total protein contents and their pattern in E. coli cells. The EF-treatment did not show any influence on the level of the argE3(ochre) --> Arg(+) reversions.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11551485     DOI: 10.1016/s1383-5718(01)00212-1

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  1 in total

1.  The growth of Staphylococcus aureus and Escherichia coli in low-direct current electric fields.

Authors:  Dunya Zituni; Heidi Schütt-Gerowitt; Marion Kopp; Martin Krönke; Klaus Addicks; Christian Hoffmann; Martin Hellmich; Franz Faber; Wilhelm Niedermeier
Journal:  Int J Oral Sci       Date:  2013-09-06       Impact factor: 6.344

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.